The Commission sought to define clinical obesity as a condition of illness that, akin to the notion of chronic disease in other medical specialties, directly results from the effect of excess adiposity on the function of organs and tissues.
This study examines the historical trends of the global, regional, and national prevalence of adult overweight and obesity from 1990 to 2021 and forecast the future trajectories to 2050, finding rates of overweight and obesity increased at the global and regional levels, and in all nations, between 1990 and 2021.
These revised evidence-based recommendations inform clinical decision-making in the management of DTC that reflect the changing science and optimize the evidence-based clinical care of patients throughout their journey with DTC.
The overall observed prevalence estimate was similar to estimates calculated using Bayesian hierarchical and random effects models, and ASD prevalence was lower among non-Hispanic White (White) children than among Asian or Pacific Islander (A/PI) children (27.7) than among Asian or Pacific Islander (A/PI) children (38.5).
The updated CONSORT 2025 statement is presented, which aims to account for recent methodological advancements and feedback from end users and developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item.
The development of PROBAST+AI is described, which may replace the original PROBAST tool and allows all key stakeholders to examine the quality, risk of bias, and applicability of any type of prediction model in the healthcare sector, irrespective of whether regression modelling or AI techniques are used.
This work presents the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users and develops an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item.
This data indicates that RNA Interference and Non-coding RNAs in Surgical Oncology and Experimental Therapeutics, as well as RNA Interference and Non-coding RNAs in Gene Regulation, at the University of Texas MD Anderson Cancer Center are likely to be influenced by each other.
Global and regional forecasts of AMR burden until 2050 are produced for three scenarios: a reference scenario that is a probabilistic forecast of the most likely future; a Gram-negative drug scenario that assumes future drug development that targets Gram-negative pathogens; and a better care scenario that assumes future improvements in health-care quality and access to appropriate antimicrobials.
The goal of the current document is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues.
The new AlphaFold model demonstrates substantially improved accuracy over many previous specialized tools: far greater accuracy for protein–ligand interactions compared with state-of-the-art docking tools, much higher accuracy for protein–nucleic acid interactions compared with nucleic-acid-specific predictors and substantially higher antibody–antigen prediction accuracy.
Two below-threshold surface code memories on Willow, a distance-7 code and a distance-5 code integrated with a real-time decoder, indicate device performance that, if scaled, could realize the operational requirements of large-scale fault-tolerant quantum algorithms.
The combined burden of underweight and obesity has increased in most countries, driven by an increase in obesity, while underweight and thinness remain prevalent in south Asia and parts of Africa.
Cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model, a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations, and combine those results to produce cause-specific mortality estimates.
Code development continues in line with the Galaxy Project roadmap, with improvements to job scheduling and the user interface, and general purpose graphical processing units (GPGPU) access for cutting-edge methods, and licensed tool support.
The status of InterPro is reported on, detailing new developments in the database, associated web interface and software, including the increased integration of structures predicted by AlphaFold and the enhanced description of protein families using artificial intelligence.
In the coming decades, the relatively constant age-standardized prevalence of global CVD suggests that the net effect of summative preventative efforts will likely continue to be unchanged.
In the past two years, significant updates were made to PubChem, including the co-occurrence data underlying the literature knowledge panel, enabling users to exploit semantic web technologies to explore entity relationships based on the co-occurrences in the scientific literature.
Economic and epidemiological data underscore why kidney disease should be placed on the global public health agenda — kidney disease prevalence is increasing globally and it is now the seventh leading risk factor for mortality worldwide.
The roles of EVs across various conditions, including cancers, neurodegenerative disorders, diabetes, viral infections, autoimmune and renal diseases, are discussed, emphasizing the potential advancements in molecular diagnostics and drug delivery.
Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high‐quality screening and treatment.
Virchow is presented, the largest foundation model for computational pathology to date, and it is demonstrated that a large foundation model enables pan-cancer detection, achieving 0.95 specimen-level area under the receiver operating characteristic curve across nine common and seven rare cancers.
Greater exposure to ultra-processed food was associated with a higher risk of adverse health outcomes, especially cardiometabolic, common mental disorder, and mortality outcomes, and these findings provide a rationale to develop and evaluate the effectiveness of using population based and public health measures to target and reduce dietary exposure to ultra-processed foods for improved human health.
GenCast, a probabilistic weather model using artificial intelligence for weather forecasting, has greater skill and speed than the top operational medium-range weather forecast in the world and provides probabilistic, rather than deterministic, forecasts.
Most countries, especially in low-income and middle-income countries, diabetes treatment has not increased at all or has not increased sufficiently in comparison with the rise in prevalence, and the burden of diabetes and untreated diabetes is increasingly borne by low-income and middle-income countries.
Co-Scientist, a multi-agent artificial intelligence system built on Gemini for structured scientific thinking and hypothesis generation, helped to identify new drug-repurposing candidates and synergistic combination therapies for acute myeloid leukaemia that were validated through in vitro experiments.
Adjuvant mRNA-4157 plus pembrolizumab prolonged recurrence-free survival versus pembrolizumab monotherapy in patients with resected high-risk melanoma and showed a manageable safety profile provides evidence that an mRNA-based individualised neoantigen therapy might be beneficial in the adjuvant setting.
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a significantly lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo.
The current scope of data accessible through NCBI Datasets is outlined and various options for exploring and downloading the data are explained, facilitating improved data retrieval, sharing, and usability in research.
The new Ensembl site, currently in beta, has continued to develop, currently holding >2700 eukaryotic genome assemblies and will replace the current Rapid Release site, and represents a key step towards provision of a single integrated Ensembl site.
Existing evaluations of LLMs mostly focus on accuracy of question answering for medical examinations, without consideration of real patient care data, and future evaluations should adopt standardized applications and metrics, use clinical data, and broaden focus to include a wider range of tasks and specialties.
The content featured in this issue focuses on the recommendations for overall management of systemic therapy (preoperative and adjuvant) options for nonmetastatic breast cancer.
GPT-4 significantly outperforms both human test-takers and prior models, demonstrating a 26% increase over ChatGPT and beating humans in five of seven subject areas, document not just the rapid and remarkable advance of large language model performance generally, but also the potential for such models to support the delivery of legal services in society.
This study enables comparisons of the impact of causes of death over time, offering a deeper understanding of how these causes affect global populations, and produces cause-specific mortality estimates measured in counts, rates, and years of life lost.
This analysis aimed to present global CKD estimates using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 to inform evidence-based policies for CKD identification and treatment to inform evidence-based policies for CKD treatment.
Gains in future life expectancy were forecasted to be greatest in super-regions with comparatively low life expectancies compared with super-regions with higher life expectancies (such as the high-income super-region), leading to a trend towards convergence in life expectancy across locations between now and 2050.
This clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).
Article Galaxy Pages is a free service from Research Solutions, a company that offers access to content in collaboration with publishing partners, online repositories and discovery services.